Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Block Listing Return

7 Jan 2020 10:17

RNS Number : 9931Y
Oxford Biomedica PLC
07 January 2020
 

For Immediate Release

07 January 2020

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 July 2019

To:

31 December 2019

Balance of unallotted securities under scheme(s) from previous return:

31,157

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

20,301

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

10,856

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 July 2019

To:

31 December 2019

Balance of unallotted securities under scheme(s) from previous return:

270,875

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

270,875

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 July 2019

To:

31 December 2019

Balance of unallotted securities under scheme(s) from previous return:

102,346

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

102,346

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 July 2019

To:

31 December 2019

Balance of unallotted securities under scheme(s) from previous return:

237,224

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

78,180

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

159,044

 

 

 

Name of contact:

Natalie Walter

Telephone number of contact:

01865 783000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRBRMMTMTBMBIM
Date   Source Headline
22nd Jan 20262:16 pmRNSForm 8.3 Oxford Biomedica Plc
22nd Jan 20269:33 amRNSForm 8.5 (EPT/RI)-Oxford Biomedica plc
22nd Jan 20269:31 amRNSForm 8.5 (EPT/NON-RI)-Oxford Biomedica plc
22nd Jan 20267:00 amRNSRule 2.9 Announcement
21st Jan 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
21st Jan 20262:08 pmRNSForm 8.3 - Oxford Biomedica Plc
21st Jan 20261:57 pmRNSForm 8.3 Oxford Biomedica plc
21st Jan 202612:05 pmRNSForm 8.3 - Oxford Biomedica plc
21st Jan 20268:35 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
21st Jan 20268:28 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
20th Jan 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
20th Jan 20262:51 pmRNSForm 8.3 - Oxford Biomedica PLC
20th Jan 202611:45 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
20th Jan 20269:34 amRNSForm 8.5 (EPT/NON-RI) Oxford Biomedica Plc
20th Jan 20267:47 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
20th Jan 20267:45 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
19th Jan 202611:48 amRNSForm 8.3 - Oxford Biomedica plc
19th Jan 202610:35 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
19th Jan 202610:08 amRNSForm 8.5 (EPT/NON-RI) Oxford Biomedica Plc
19th Jan 20267:00 amRNSRule 2.9 Announcement
16th Jan 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
16th Jan 20261:34 pmRNSForm 8.3 OXFORD BIOMEDICA PLC
16th Jan 202610:05 amRNSForm 8.5 (EPT/NON-RI) Oxford Biomedica Plc
16th Jan 20269:32 amRNSForm 8.3 - Oxford Biomedica plc
16th Jan 20268:54 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
16th Jan 20268:52 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
15th Jan 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
15th Jan 20263:17 pmRNSForm 8.3 - Oxford Biomedica plc
15th Jan 20262:39 pmEQSForm 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc
15th Jan 20261:59 pmRNSForm 8.3 - OXFORD BIOMEDICA PLC
15th Jan 20261:31 pmRNSForm 8.3 OXFORD BIOMEDICA PLC
15th Jan 202612:29 pmRNSForm 8.3 - Oxford Biomedica plc
15th Jan 20269:21 amRNSForm 8.3 - Oxford Biomedica plc
14th Jan 20265:17 pmRNSDisclosure Table
14th Jan 20264:49 pmRNSResponse to press speculation
2nd Jan 20267:00 amRNSBlock Listing Return
2nd Jan 20267:00 amRNSBlock Listing Return
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
8th Dec 20253:15 pmRNSPDMR Dealing
1st Dec 20257:00 amRNSTotal Voting Rights
3rd Nov 20254:55 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
29th Oct 20251:59 pmRNS-ROXB honoured at 2025 CDMO Leadership Awards Europe
27th Oct 20257:00 amRNS-ROXB to participate in investor conferences
20th Oct 20255:54 pmRNSDirector/PDMR Shareholding
20th Oct 20255:13 pmRNSDirector/PDMR Shareholding
20th Oct 202510:17 amRNSBoard Change
16th Oct 20257:00 amRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSAcquisition of US viral vector facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.